Director/PDMR Shareholding

Barclays PLC
15 March 2006


                                                                   15 March 2006

   Director/PDMR Shareholding: Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b)

1.  The independent trustee of the Barclays Group (ESAS) Employees' Benefit 
    Trust (the 'ESAS Trust') notified the Company on 14 March 2006 that it had 
    between 8 March and 10 March 2006 exercised its discretion and purchased a
    total of 17,054,723 ordinary shares in Barclays PLC at an average price of
    650.21p per share and between 8 March and 13 March 2006 released a total of
    20,185,098 ordinary shares in Barclays PLC to participants in the Executive
    Share Award Scheme ('ESAS'). The shares were released following provisional
    allocations made by the trustee over Barclays PLC ordinary shares to
    participants in the ESAS. Of these shares, the following were released to
    directors and PDMRs of Barclays PLC:

    Directors/         Shares         Shares sold   Price per   Shares retained
    PDMRS              released       on behalf     share       retained by 
                       to Director/   of directors  (pence)     Director/PDMR
                       PDMRs    
     
    Mr N Kheraj        225,320        92,428        662.25      132,892
    Mr RE Diamond Jr   1,389,360      588,120       662.25      801,240
    Mr GA Hoffman      243,027        99,692        662.25      143,335
    Mr DL Roberts      237,114        97,266        662.25      139,848
    Mr JS Varley       24,790         10,169        662.25      14,621
    Mr PT Idzik        297,080        121,865       662.25      175,215
    Mr LC Dickinson    8,856          3,633         662.25      5,223


2.  The independent trustee of the Barclays Group (ESAS) Employees' Benefit 
    Trust (the 'ESAS Trust') notified the Company on 14 March 2006 that it
    had on 13 March 2006 granted rights in the form of nil cost options to the
    directors and PDMRs of Barclays PLC listed below under the Barclays PLC
    Executive Share Award Scheme ('ESAS'), to acquire ordinary shares in 
    Barclays PLC. The ESAS options are exercisable from grant until 28 February 
    2008 and are granted over a proportion of shares which were originally 
    provisionally allocated by the trustee under ESAS on 28 February 2003 to 
    the directors and PDMRs listed below.

    The number of shares under option includes an additional number of shares 
    which have been accrued in respect of dividends received by the trustee 
    since February 2003. The total exercise price payable on any exercise of an 
    ESAS option is £1.

    Director/PDMR      Number of shares granted under option to Directors/PDMRs

    Mr GA Hoffman      20,112
    Mr N Kheraj        245,011
    Mr DL Roberts      18,282
    Mr JS Varley       24,790
    Mr R Le Blanc      167,877

    The revised total shareholding for each director following these 
    transactions is as follows:

    Director           Beneficial Holding

    Mr N Kheraj        141,442
    Mr RE Diamond Jr   2,501,772
    Mr GA Hoffman      317,105
    Mr DL Roberts      218,099
    Mr JS Varley       374,730


3.  In addition Paul Idzik notified the Company on 14 March 2006 that on 
    14 March 2006 he sold 53,676 shares at a price of 666.48p per share.

Following these transactions, the trustees of all the Barclays Group employees'
benefit trusts hold a total of 165,780,967 ordinary shares in Barclays PLC.
Matthew W. Barrett, Chairman, and the executive directors of Barclays are
amongst the potential beneficiaries under these trusts and are therefore
regarded for Companies Act purposes as being interested in the Barclays PLC
ordinary shares held in them.




                      This information is provided by RNS
            The company news service from the London Stock Exchange